Endogenous hydrogen sulfide in patients with COPD

被引:245
作者
Chen, YH [1 ]
Yao, WZ
Geng, B
Ding, YL
Lu, M
Zhao, MW
Tang, CS
机构
[1] Peking Univ, Hosp 3, Resp Dept, Beijing 100083, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Dept Physiol, Beijing 100871, Peoples R China
基金
中国国家自然科学基金;
关键词
airway inflammation; airway obstruction; COPD; hydrogen sulfide; nitric oxide;
D O I
10.1378/chest.128.5.3205
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: COPD is characterized by progressive airway obstruction. Recent studies showed that besides nitric oxide (NO) and carbon monoxide (CO), endogenous hydrogen sulfide (H2S) might be the third signaling gasotransmitter. To clarify the role of endogenous H,S in the pathogenesis of COPD, we investigated the relation of serum H2S level to severity of COPD as defined by lung function and airway inflammation. Methods: Levels Of Serum H2S and NO, lung function, and cell differential counts in induced sputum were studied in 27 patients with acute exacerbation of COPD (AECOPD), 37 patients with stable COPD, and 13 healthy subjects. Patients with AECOPD had arterial blood gas levels measured and underwent Doppler echocardiography. In addition, in order to clarify the effects of age and smoking status on serum H2S level, we recruited three groups who were age matched to the study group but had no airflow hinitation (59 subjects). Results: Serum H2S level (34.0 +/- 0.9 to 36.4 +/- 1.1 mu mol/L [+/- SEM]) did not differ among healthy control subjects with different ages (56.6 to 75.0 years, respectively). Serum H2S level was significantly higher in patients with stable COPD than in patients with AECOPD and age-matched control subjects (p < 0.01) and correlated positively with NO level in all healthy control subjects and all patients with COPD (r = 0.352, p = 0.000). Serum H2S level was significantly lower in smokers than nonsmokers, both with AECOPD (p < 0.05) and healthy control subjects (p < 0.01). It was significantly lower in smokers with AECOPD than healthy smokers and smokers with stable COPD (p < 0.01). Serum H2S level differed and was decreased (p < 0.05) among stable COPD patients by stage of airway obstruction (p < 0.05), and it was lower in patients with stage III than stage I obstruction (p < 0.05). Serum H2S level in all patients with COPD and healthy control subjects con-elated positively with the percentage of predicted FEV1 value (r = 0.300, p = 0.009). It was lower in patients with AECOPD and systolic pulmonary artery pressure (PASP) >= 35 mm Hg than those with PASP within the normal range (< 35 mm 14g) [p < 0.05] and was negatively correlated with PASP (r = - 0.561, p = 0.011). Serum H2S level was negatively correlated with proportion of neutrophils in sputuni (r = -0.422, p = 0.001) and positively correlated with proportion of lymphocytes (r = 0.286, p = 0.028) and niacrophages (r = 0.334, p = 0.01) in all patients with COPD. Conclusions: Endogenous H2S is involved in the pathogenesis of airway obstruction in COPD, and its alteration in level may be connected with disease activity and severity.
引用
收藏
页码:3205 / 3211
页数:7
相关论文
共 27 条
  • [1] *AM THOR SOC, 1995, THORAX, V152, P78
  • [2] [Anonymous], CHIN J TUBERCULOSIS
  • [3] Use of nitric oxide inhalation in chronic obstructive pulmonary disease
    Ashutosh, K
    Phadke, K
    Jackson, JF
    Steele, D
    [J]. THORAX, 2000, 55 (02) : 109 - 113
  • [4] BARNES PJ, 1995, ANN MED, V27, P91
  • [5] A CRITICAL-REVIEW OF THE LITERATURE ON HYDROGEN-SULFIDE TOXICITY
    BEAUCHAMP, RO
    BUS, JS
    POPP, JA
    BOREIKO, CJ
    ANDJELKOVICH, DA
    [J]. CRC CRITICAL REVIEWS IN TOXICOLOGY, 1984, 13 (01): : 25 - 97
  • [6] Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease
    Corradi, M
    Majori, M
    Cacciani, GC
    Consigli, GF
    de'Munari, E
    Pesci, A
    [J]. THORAX, 1999, 54 (07) : 572 - 575
  • [7] The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells
    Du, JB
    Hui, Y
    Cheung, YF
    Bin, G
    Jiang, HF
    Chen, XB
    Tang, CS
    [J]. HEART AND VESSELS, 2004, 19 (02) : 75 - 80
  • [8] RETRACTED: Brain hydrogen sulfide is severely decreased in Alzheimer's disease (Retracted Article)
    Eto, K
    Asada, T
    Arima, K
    Makifuchi, T
    Kimura, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (05) : 1485 - 1488
  • [9] Eto K, 2002, J NEUROSCI, V22, P3386
  • [10] Global strategy for the diagnosis, management and prevention of COPD: 2003
    Fabbri, LM
    Hurd, SS
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (01) : 1 - 2